Terms: = Gastric cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
131 results:
1. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
2. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mtor signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
3. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mtor-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
4. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
5. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mtor Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract] [Full Text] [Related]
6. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/AKT/mtor signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract] [Full Text] [Related]
7. [Preliminary Investigation of the Molecular Mechanism of Empagliflozin Suppressing gastric cancer Through Mammalian Target of Rapamycin].
Rao H; Cheng W; Yu J; An X; Deng H; Zhang Z; Wu F; Ji F; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1146-1153. PubMed ID: 38162062
[TBL] [Abstract] [Full Text] [Related]
8. Dual PI3K/mtor inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract] [Full Text] [Related]
9. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
10. Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mtor pathway in gastric cancer.
Jin Y; Xia Y; Du H; Xiang T; Lan B; Wei S; Li H; Huang H
Biochem Biophys Res Commun; 2023 Dec; 689():149188. PubMed ID: 37976838
[TBL] [Abstract] [Full Text] [Related]
11. miR-1304 targets KLK11 to regulate gastric cancer cell proliferation through the mtor signaling pathway.
Ding Y; Wang Z; Chen C; Li D; Wang W; Jia Y; Qin Y
Carcinogenesis; 2024 Feb; 45(1-2):45-56. PubMed ID: 37971062
[TBL] [Abstract] [Full Text] [Related]
12. Loss of ATOH1 in Pit Cell Drives Stemness and Progression of gastric Adenocarcinoma by Activating AKT/mtor Signaling through GAS1.
Zhong Q; Wang HG; Yang JH; Tu RH; Li AY; Zeng GR; Zheng QL; Yu Liu Z; Shang-Guan ZX; Bo Huang X; Huang Q; Li YF; Zheng HL; Lin GT; Huang ZN; Xu KX; Qiu WW; Jiang MC; Zhao YJ; Lin JX; Huang ZH; Huang JM; Li P; Xie JW; Zheng CH; Chen QY; Huang CM
Adv Sci (Weinh); 2023 Nov; 10(32):e2301977. PubMed ID: 37824217
[TBL] [Abstract] [Full Text] [Related]
13. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
14. Genomic and Transcriptomic Characterization of gastric cancer with Bone Metastasis.
Oh S; Nam SK; Lee KW; Lee HS; Park Y; Kwak Y; Lee KS; Kim JW; Kim JW; Kang M; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH
Cancer Res Treat; 2024 Jan; 56(1):219-237. PubMed ID: 37591783
[TBL] [Abstract] [Full Text] [Related]
15. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target.
Yun WJ; Zhang L; Yang N; Cui ZG; Jiang HM; Ha MW; Yu DY; Zhao MZ; Zheng HC
Drug Dev Res; 2023 Nov; 84(7):1537-1552. PubMed ID: 37571819
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract] [Full Text] [Related]
17. YWHAH activates the HMGA1/PI3K/AKT/mtor signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells.
He J; Zeng F; Jin XI; Liang L; Gao M; Li W; Li G; Zhou Y
Oncol Res; 2023; 31(4):615-630. PubMed ID: 37415737
[TBL] [Abstract] [Full Text] [Related]
18. Estradiol cypionate inhibits proliferation and promotes apoptosis of gastric cancer by regulating AKT ubiquitination.
Qiu X; Wang J; Zhang N; Du T; Chen L; Xi H
Biomed Pharmacother; 2023 Sep; 165():115073. PubMed ID: 37392652
[TBL] [Abstract] [Full Text] [Related]
19. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract] [Full Text] [Related]
20. Machine learning models predict the mtor signal pathway-related signature in the gastric cancer involving 2063 samples of 7 centers.
Zhang H; Zhuo H; Hou J; Cai J
Aging (Albany NY); 2023 Jun; 15(13):6152-6162. PubMed ID: 37341987
[TBL] [Abstract] [Full Text] [Related]
[Next]